NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol.

Author(s): Prezeau N, Silvy M, Gabert J, Picard C

Publication: Leuk Res, 2006, Vol. 30, Page 569-74

PubMed ID: 16209886 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of stabilization and extraction of RNA with the Tempus system on RNA quality and quantity.

Conclusion of Paper

The RNA yield was lower from PAXgene- or Tempus-stabilized and extracted specimens than from unstabilized, Ficoll/Trizol-extracted specimens, but the RNA quality, as assessed by bioanalyzer, the ratio of beta-glucuronidase (GUS) to Abelson murine leukemia viral oncogene homolog 1 (ABL) transcripts, and the sensitivity for detection of breakpoint cluster region (BCR)-ABL fusion gene (FG) transcripts were similar between methods. Although 20% of Tempus specimens showed slight degradation when RNA was extracted immediately, no changes in RNA yield or the 28S /18S ribosomal RNA (rRNA) ratio were found after blood was stored for 6 months, in Tempus tubes, at any temperature, prior to extraction. In contrast, the RNA yield from EDTA-blood was stable for the first three days of storage at room temperature, but the yield decreased by 50% when EDTA-blood was stored for 5 days at room temperature. BCR-ABL FG normalized to ABL was stable in blood stored in Tempus tubes for 45 days at room temperature or 4 degrees C and for 6 months when specimens were stored at -20 or -80 degrees C.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of stabilization and extraction methods on RNA quality, and quantity. Pooled blood from 20 healthy individuals was divided between 6 replicate PAXgene, Tempus and EDTA tubes. RNA extracted using PAXgene and Tempus was concentrated before being reverse transcribed according to the Europe Against Cancer (EAC) protocol. For determining the sensitivity of detecting BCR-ABL FG transcripts, different percentages of K562 cells carrying the BCR-ABL FG were mixed into the blood.

    Summary of Findings:

    The RNA yield from unstabilized EDTA-blood extracted using Ficoll/Trizol was 9 ug, while 6 ug of RNA were isolated from PAXgene-stabilized and extracted blood and 3 ug were isolated from Tempus-stabilized and extracted blood. The RNA quality, as assessed by bioanalyzer, was similar between the three methods, but a third ribosomal peak (5S) was present in Trizol-extracted specimens, and 20% of Tempus specimens showed slight degradation. While cycle threshold (CT) values depended on the extraction and stabilization methods used, the ratio of the GUS to ABL transcripts were similar between methods. The sensitivity of detection of BCR-ABL FG transcripts was similar between differently extracted specimens.

    Biospecimens
    Preservative Types
    • Other Preservative
    • None (Fresh)
    • PAXgene
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    RNA Spectrophotometry
    RNA Real-time qRT-PCR
    RNA Automated electrophoresis/Bioanalyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation None (fresh)
    PAXgene
    Tempus
    Analyte Extraction and Purification Analyte isolation method PAXgene blood kit
    Tempus blood RNA kit
    EDTA blood with Ficoll/Trizol extraction
    Real-time qRT-PCR Specific Targeted nucleic acid ABL
    GUS
    BCR-ABL
  2. Study Purpose

    The purpose of this study was to determine the effects of storage of blood in Tempus instead of EDTA tubes on RNA yield and recovery of BCR-ABL FG transcripts from spiked specimens. Blood from 3 healthy individuals was mixed with 1% K562 cells carrying the BCR-ABL FG. RNA was extracted from blood in Tempus tubes using the Tempus blood kit and from blood in EDTA tubes using a Ficoll/Trizol method.

    Summary of Findings:

    The RNA yield from EDTA-blood was stable for the first three days of storage at room temperature, but the yield decreased by 50% when EDTA-blood was stored for 5 days at room temperature. In contrast, RNA yield was not affected by storage of blood at room temperature for 5 days in Tempus tubes. Further, specimens stored in EDTA tubes had increased IL8 and decreased BCR-ABL levels after 5 days, but this was not found for specimens stored in Tempus tubes. The ratio of BCR-ABL FG/ABL was stable in blood stored in Tempus tubes for 45 days at room temperature or 4 degrees C or when stored for 6 months at -20 or -80 degrees C. The authors report that storage of blood in Tempus tubes for up to 6 months at any temperature had no effects on RNA yield or 28S/18S rRNA ratio.

    Biospecimens
    Preservative Types
    • Other Preservative
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    RNA Spectrophotometry
    RNA Automated electrophoresis/Bioanalyzer
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Type of storage container Tempus tube
    EDTA tube
    Storage Time at room temperature 0 days
    1 day
    3 days
    5 days
    Storage Storage temperature -80 degrees C
    -20 degrees C
    4 degrees C
    22 degrees C
    Storage Storage duration 0 days
    45 days
    3 months
    6 months
    Biospecimen Preservation Type of fixation/preservation None (fresh)
    Tempus
    Frozen
    Refrigeration
    Real-time qRT-PCR Specific Targeted nucleic acid BCR-ABL
    IL8
    ABL
    28s/18s rRNA

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...